Results 11 to 20 of about 470,350 (340)

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors. [PDF]

Clinical Cancer Research, 2020
PurposeImmune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti-CTLA-4 and ...
Baghdadi, Tareq Al, Blanke, Charles D, Chae, Young Kwang, Chen, Helen X, Fontaine, Annette, Gatalica, Zoran, Giles, Francis J, Hansel, Donna E, Hayward, Jourdain, Kasi, Anup, Korn, W Michael, Kurzrock, Razelle, Matrana, Marc, Mayerson, Edward, McLeod, Christine, Othus, Megan, Patel, Sandip P, Plets, Melissa, Ryan, Christopher W, Shah, Manisha H, Sharon, Elad, Singh, Preet Paul   +21 more
core   +2 more sources

Neuroendocrine Tumors [PDF]

Journal of the National Comprehensive Cancer Network, 2012
Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade
Matthew H, Kulke, Al B, Benson, Emily, Bergsland, Jordan D, Berlin, Lawrence S, Blaszkowsky, Michael A, Choti, Orlo H, Clark, Gerard M, Doherty, James, Eason, Lyska, Emerson, Paul F, Engstrom, Whitney S, Goldner, Martin J, Heslin, Fouad, Kandeel, Pamela L, Kunz, Boris W, Kuvshinoff, Jeffrey F, Moley, Venu G, Pillarisetty, Leonard, Saltz, David E, Schteingart, Manisha H, Shah, Stephen, Shibata, Jonathan R, Strosberg, Jean-Nicolas, Vauthey, Rebekah, White, James C, Yao, Deborah A, Freedman-Cass, Mary A, Dwyer   +27 more
openaire   +4 more sources

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas ...
M. Shah, W. Goldner, A. Benson, E. Bergsland, L. Blaszkowsky, P. Brock, J. Chan, Satya Das, P. Dickson, P. Fanta, T. Giordano, T. Halfdanarson, D. Halperin, Jin He, A. Heaney, M. Heslin, F. Kandeel, A. Kardan, S. Khan, B. Kuvshinoff, C. Lieu, Kimberly J. Miller, V. Pillarisetty, D. Reidy, S. A. Salgado, Shagufta Shaheen, H. Soares, M. Soulen, J. Strosberg, C. Sussman, Nikolaos A. Trikalinos, Nataliya A Uboha, Namrata Vijayvergia, T. Wong, B. Lynn, Cindy Hochstetler   +35 more
semanticscholar   +1 more source

European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours

Journal of neuroendocrinology, 2023
This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working group, and provides up‐to‐date and practical advice on the management of these tumours ...
B. Kos-Kudła, Justo P. Castaño, T. Denecke, E. Grande, Andreas Kjaer, A. Koumarianou, L. de Mestier, S. Partelli, A. Perren, S. Stättner, Juan W. Valle, Nicola Fazio   +11 more
semanticscholar   +1 more source

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3

Journal of neuroendocrinology, 2023
The aim of the present guidance paper was to update the previous ENETS guidelines on well‐differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal ...
F. Panzuto, J. Ramage, D. Pritchard, M. F. Velthuysen, J. Schrader, N. Begum, A. Sundin, M. Falconi, D. O’Toole   +8 more
semanticscholar   +1 more source

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours

Journal of neuroendocrinology, 2023
This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format.
A. Rinke, V. Ambrosini, C. Dromain, R. García-Carbonero, A. Haji, A. Koumarianou, E. N. V. van Dijkum, D. O’Toole, G. Rindi, J. Scoazec, J. Ramage   +10 more
semanticscholar   +1 more source

Gastric Neuroendocrine Tumor [PDF]

The Surgery Journal, 2021
AbstractGastric neuroendocrine tumor (gNET) is a rare carcinoid of the stomach whose incidence is increasing due to widespread use of upper gastrointestinal endoscopy (UGIE). There are four types of gNETs with different management strategies and prognosis. Here, we present a patient who came with abdomen pain and intermittent melena.
Naresh Kargwal, Viraj Panda, Abhijeet Kumar Jha, C. B. Singh   +3 more
openaire   +3 more sources

Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors

Diagnostics, 2020
Background: Plasma chromogranin A (CgA) is related to tumor burden and recommended in the follow-up of patients diagnosed with neuroendocrine tumors (NETs). The use of CgA in the workup of a suspected NET is more questionable.
Jonas Baekdal, Jesper Krogh, Marianne Klose, Pernille Holmager, Seppo W. Langer, Peter Oturai, Andreas Kjaer, Birgitte Federspiel, Linda Hilsted, Jens F. Rehfeld, Ulrich Knigge, Mikkel Andreassen   +11 more
doaj   +1 more source

Timing of maternal exposure and fetal sex determine the effects of low-level chemical mixture exposure on the fetal neuroendocrine system in sheep [PDF]

, 2016
We have shown that continuous maternal exposure to the complex mixture of environmental chemicals (ECs) found in human biosolids (sewage sludge), disrupts mRNA expression of genes crucial for development and long-term regulation of hypothalamo-pituitary ...
Bellingham, M., Cotinot, C., Evans, N.P., Fowler, P.A., MacDonald, E.S., Mandon-Pepin, B., Rhind, S., Sharpe, R.M.   +7 more
core   +2 more sources

Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature [PDF]

, 2017
Background: Simultaneous occurrence of exocrine and neuroendocrine tumors of the pancreas is very infrequent. We report a patient with an endocrine tumor in the pancreatic-duodenal area and extensive exocrine carcinoma involving the whole pancreas.
Blandamura, Stella, Da Dalt, Gianfranco, Merigliano, Stefano, Pozza, Gioia, Serafini, Simone, Sperti, Cosimo, Valmasoni, Michele   +6 more
core   +2 more sources